Does BELIMUMAB Cause Product dose omission issue? 4,671 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 4,671 reports of Product dose omission issue have been filed in association with BELIMUMAB (BENLYSTA). This represents 17.5% of all adverse event reports for BELIMUMAB.
4,671
Reports of Product dose omission issue with BELIMUMAB
17.5%
of all BELIMUMAB reports
11
Deaths
358
Hospitalizations
How Dangerous Is Product dose omission issue From BELIMUMAB?
Of the 4,671 reports, 11 (0.2%) resulted in death, 358 (7.7%) required hospitalization, and 2 (0.0%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELIMUMAB. However, 4,671 reports have been filed with the FAERS database.
What Other Side Effects Does BELIMUMAB Cause?
Systemic lupus erythematosus (3,388)
Fatigue (1,650)
Drug ineffective (1,570)
Pain (1,510)
Wrong technique in device usage process (1,347)
Injection site pain (1,279)
Malaise (1,257)
Headache (1,207)
Arthralgia (1,114)
Nausea (1,091)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
SECUKINUMAB (4,572)
APREMILAST (4,460)
GOLIMUMAB (4,216)
Which BELIMUMAB Alternatives Have Lower Product dose omission issue Risk?
BELIMUMAB vs BELINOSTAT
BELIMUMAB vs BELUMOSUDIL
BELIMUMAB vs BELVIQ
BELIMUMAB vs BELZUTIFAN
BELIMUMAB vs BEMPEDOIC ACID